iBio, Inc. (NYSE MKT: IBIO), a leader in the plant-made pharmaceutical field, develops and offers pharmaceutical product applications using its iBio Technology platform.
The iBio Technology platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins and vaccines.
Stay informed and receive company updates straight to your inboxSign up today
Investor Contact Information
600 Madison Avenue
New York, NY 10022
Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004